Kalish R A, Leong J M, Steere A C
Division of Rheumatology/Immunology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Infect Immun. 1995 Jun;63(6):2228-35. doi: 10.1128/iai.63.6.2228-2235.1995.
The immunoglobulin G (IgG) antibody response to outer surface protein A (OspA) of Borrelia burgdorferi has been reported to occur late in the course of Lyme disease. To learn when reactivity to particular epitopes of OspA develops and whether the strength of particular responses correlates with the duration of arthritis and HLA-DR specificities, we determined the IgM and IgG responses by enzyme-linked immunosorbent assay in 128 patients with various manifestations of Lyme disease to full-length recombinant OspA and three OspA fragments which divided the protein approximately into thirds. Among the 10 patients who were followed serially, an early IgM response was often found to epitopes in all three fragments of OspA, sometimes accompanied by a weak IgG response, primarily to an epitope in the middle third of the protein. Months to years later, the seven patients who had prolonged or moderate episodes of arthritis developed strong IgG responses to OspA, especially to epitopes in the N-terminal and C-terminal fragments, that paralleled the course of the arthritis. In single serum samples from 128 patients, a similar pattern of IgM and IgG reactivity with OspA epitopes was seen in patients with early or late manifestations of the illness. Of the 80 patients with arthritis, 62 (78%) had IgG responses to OspA, usually with the strongest reactivity to the C-terminal fragment. In these patients, the strength of the IgG response to OspA correlated with the duration of arthritis; in HLA-DR4-positive patients, most of whom had chronic arthritis, this association was attributable to reactivity with the C-terminal fragment. Thus, patients with Lyme disease often have early responses to OspA, but those with prolonged arthritis do not develop IgG responses to certain epitopes of the protein until late in the illness. In patients with HLA-DR4, the strength of IgG reactivity with one or more epitopes in the C-terminal fragment of OspA correlates with the duration of arthritis.
据报道,针对伯氏疏螺旋体外膜蛋白A(OspA)的免疫球蛋白G(IgG)抗体反应在莱姆病病程后期出现。为了了解对OspA特定表位的反应性何时出现,以及特定反应的强度是否与关节炎持续时间和HLA - DR特异性相关,我们通过酶联免疫吸附测定法,检测了128例有莱姆病各种表现的患者针对全长重组OspA和将该蛋白大致分为三分之一的三个OspA片段的IgM和IgG反应。在10例接受连续检测的患者中,通常发现对OspA所有三个片段的表位都有早期IgM反应,有时伴有微弱的IgG反应,主要针对蛋白中间三分之一处的一个表位。数月至数年之后,7例有持续性或中度关节炎发作的患者对OspA产生了强烈的IgG反应,尤其是对N端和C端片段的表位,这与关节炎病程平行。在128例患者的单次血清样本中,疾病早期或晚期表现的患者对OspA表位的IgM和IgG反应模式相似。在患有关节炎的80例患者中,62例(78%)对OspA有IgG反应,通常对C端片段反应最强。在这些患者中,对OspA的IgG反应强度与关节炎持续时间相关;在HLA - DR4阳性患者中,大多数患有慢性关节炎,这种关联归因于对C端片段的反应性。因此,莱姆病患者通常对OspA有早期反应,但患有持续性关节炎的患者直到疾病后期才对该蛋白的某些表位产生IgG反应。在HLA - DR4患者中,对OspA C端片段一个或多个表位的IgG反应强度与关节炎持续时间相关。